
PFSA
Healthcare · Medical Devices · $271,329 market cap
$0.4480-0.01 (-2.6%)Nov 13, 4:25 PM EST
Next report
Time not confirmed
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 18, 2026 · upcoming | Time not confirmed | — | — | — |
| Aug 19, 2026 | Time not confirmed | — | -151.80 | — |
| Nov 19, 2025 | Time not confirmed | — | -0.70 | — |
| Aug 22, 2025 | Time not confirmed | — | -0.42 | — |
| Jun 27, 2025 | Time not confirmed | — | -0.48 | — |
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is…